373
Participants
Start Date
November 30, 2002
Study Completion Date
June 30, 2005
oxaliplatin
fluoropyrimidine
bevacizumab
Sanofi-Aventis, Bridgewater
Lead Sponsor
Sanofi
INDUSTRY